Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics-Reference-Cited by-同舟云学术

Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics

Published:2015-09-08 Issue:6 Volume:16 Page:519-524
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Nieuweboer A J M,Smid M,de Graan A-J M,Elbouazzaoui S,de Bruijn P,Eskens F A L M,Hamberg P,Martens J W M,Sparreboom A,de Wit R,van Schaik R H N,Mathijssen R H J

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj201566.pdf

Reference33 articles.

1. Mosteller RD . Simplified calculation of body-surface area. N Engl J Med 1987; 317: 1098.

2. Bins S, Ratain MJ, Mathijssen RH . Conventional dosing of anticancer agents: precisely wrong or just inaccurate? Clin Pharmacol Ther 2014; 95: 361–364.

3. Baker SD, Li J, ten Tije AJ, Figg WD, Graveland W, Verweij J et al. Relationship of systemic exposure to unbound docetaxel and neutropenia. Clin Pharmacol Ther 2005; 77: 43–53.

4. de Graan AJ, Loos WJ, Friberg LE, Baker SD, van der Bol JM, van Doorn L et al. Influence of smoking on the pharmacokinetics and toxicity profiles of taxane therapy. Clin Cancer Res 2012; 18: 4425–4432.

5. Wonganan P, Zamboni WC, Strychor S, Dekker JD, Croyle MA . Drug-virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model. Cancer Gene Ther 2009; 16: 405–414.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal exposure to docetaxel in adjuvant chemotherapy for early‐stage breast cancer;Journal of Clinical Pharmacy and Therapeutics;2022-11-23

2. Pharmacogenomics in Cytotoxic Chemotherapy of Cancer;Methods in Molecular Biology;2022

3. Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study;Cancer Chemotherapy and Pharmacology;2021-03-23

4. Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships;Expert Opinion on Drug Metabolism & Toxicology;2021-01-06

5. Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo‐adjuvant chemotherapy;Breast Cancer;2020-10-30